These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31638231)

  • 1. β‑elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A‑VEGFA pathway based on network pharmacology.
    Zhu J; Li B; Ji Y; Zhu L; Zhu Y; Zhao H
    Oncol Rep; 2019 Dec; 42(6):2561-2571. PubMed ID: 31638231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer.
    Kastelein AW; Vos LMC; van Baal JOAM; Koning JJ; Hira VVV; Nieuwland R; van Driel WJ; Uz Z; van Gulik TM; van Rheenen J; Ince C; Roovers JWR; van Noorden CJF; Lok CAR
    Clin Exp Metastasis; 2020 Apr; 37(2):293-304. PubMed ID: 32008138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
    Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
    Li W; Cao L; Chen X; Lei J; Ma Q
    Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway.
    Sun X; Zhang Y; Li B; Yang H
    J Recept Signal Transduct Res; 2018 Aug; 38(4):352-358. PubMed ID: 30396299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
    Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
    Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor.
    Chen X; Wu Q; You L; Chen S; Zhu M; Miao C
    Eur J Pharmacol; 2017 Jan; 795():150-159. PubMed ID: 27986626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells.
    Ding X; Zhou X; Jiang B; Zhao Q; Zhou G
    Mol Med Rep; 2015 Sep; 12(3):4508-4513. PubMed ID: 26094625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mesothelial cell effusions. Anatomo-cytological comparison].
    Marsan C; Minet F; Roujeau J
    Sem Hop; 1971 Feb; 47(9):5595. PubMed ID: 4323032
    [No Abstract]   [Full Text] [Related]  

  • 13. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.
    Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ
    J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
    Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
    Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.
    Niu F; Li Y; Lai FF; Ni L; Ji M; Jin J; Yang HZ; Wang C; Zhang DM; Chen XG
    J Cell Physiol; 2015 Sep; 230(9):2212-23. PubMed ID: 25655308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer.
    Takiguchi S; Inoue K; Matsusue K; Furukawa M; Teramoto N; Iguchi H
    Int J Oncol; 2017 Jul; 51(1):184-192. PubMed ID: 28498406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology.
    Yao J; Shen Q; Huang M; Ding M; Guo Y; Chen W; Lin Y; Zheng Y; Yu S; Yan W; Su T; Liu Z; Lu L
    J Ethnopharmacol; 2022 Jan; 282():114583. PubMed ID: 34487850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooled screening for antiproliferative inhibitors of protein-protein interactions.
    Nim S; Jeon J; Corbi-Verge C; Seo MH; Ivarsson Y; Moffat J; Tarasova N; Kim PM
    Nat Chem Biol; 2016 Apr; 12(4):275-81. PubMed ID: 26900867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
    Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
    J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.